PSNL vs. FTRE, NHC, VRDN, AHCO, AGL, CDNA, AVAH, PNTG, GRAL, and CSTL
Should you be buying Personalis stock or one of its competitors? The main competitors of Personalis include Fortrea (FTRE), National HealthCare (NHC), Viridian Therapeutics (VRDN), AdaptHealth (AHCO), agilon health (AGL), CareDx (CDNA), Aveanna Healthcare (AVAH), The Pennant Group (PNTG), Grail (GRAL), and Castle Biosciences (CSTL). These companies are all part of the "healthcare" industry.
Personalis vs.
Personalis (NASDAQ:PSNL) and Fortrea (NASDAQ:FTRE) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, community ranking, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.
In the previous week, Personalis had 13 more articles in the media than Fortrea. MarketBeat recorded 19 mentions for Personalis and 6 mentions for Fortrea. Personalis' average media sentiment score of 0.22 beat Fortrea's score of -0.07 indicating that Personalis is being referred to more favorably in the media.
Fortrea has a net margin of -10.99% compared to Personalis' net margin of -104.52%. Fortrea's return on equity of 2.00% beat Personalis' return on equity.
Personalis has a beta of 1.75, indicating that its share price is 75% more volatile than the S&P 500. Comparatively, Fortrea has a beta of 1.24, indicating that its share price is 24% more volatile than the S&P 500.
Personalis currently has a consensus target price of $7.81, suggesting a potential upside of 45.76%. Fortrea has a consensus target price of $23.30, suggesting a potential upside of 39.10%. Given Personalis' stronger consensus rating and higher possible upside, equities analysts clearly believe Personalis is more favorable than Fortrea.
Personalis received 110 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 67.60% of users gave Personalis an outperform vote while only 25.58% of users gave Fortrea an outperform vote.
61.9% of Personalis shares are held by institutional investors. 4.1% of Personalis shares are held by company insiders. Comparatively, 0.1% of Fortrea shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Fortrea has higher revenue and earnings than Personalis. Fortrea is trading at a lower price-to-earnings ratio than Personalis, indicating that it is currently the more affordable of the two stocks.
Summary
Personalis beats Fortrea on 13 of the 18 factors compared between the two stocks.
Get Personalis News Delivered to You Automatically
Sign up to receive the latest news and ratings for PSNL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Personalis Competitors List
Related Companies and Tools
This page (NASDAQ:PSNL) was last updated on 1/31/2025 by MarketBeat.com Staff
Free PSNL Stock Alerts